Clinical Trial Update: Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Participants With Previously Treated Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial updates safety and pharmacokinetics of cobimetinib in pediatric and young adult patients with previously treated solid tumors; results completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Cobimetinib (cobimetinib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Solid Tumors | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-03-31